Elevated ISM1 expression may serve as an indicator of fibrotic burden and disease progression in chronic hepatitis B. However, to date, studies exploring the role of ISM1 in chronic hepatitis B are lacking; current literature is largely restricted to its involvement in hepatic steatosis. Here, ISM1 is linked to fatty liver disease.